215 related articles for article (PubMed ID: 23201550)
1. The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi.
Bhakta N; Martiniuk AL; Gupta S; Howard SC
Arch Dis Child; 2013 Feb; 98(2):155-60. PubMed ID: 23201550
[TBL] [Abstract][Full Text] [Related]
2. The cost effectiveness of treating Burkitt lymphoma in Uganda.
Denburg AE; Laher N; Mutyaba I; McGoldrick S; Kambugu J; Sessle E; Orem J; Casper C
Cancer; 2019 Jun; 125(11):1918-1928. PubMed ID: 30840316
[TBL] [Abstract][Full Text] [Related]
3. Malawi pilot study of Burkitt lymphoma treatment.
Hesseling PB; Broadhead R; Molyneux E; Borgstein E; Schneider JW; Louw M; Mansvelt EP; Wessels G
Med Pediatr Oncol; 2003 Dec; 41(6):532-40. PubMed ID: 14595710
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of community-based management of acute malnutrition in Malawi.
Wilford R; Golden K; Walker DG
Health Policy Plan; 2012 Mar; 27(2):127-37. PubMed ID: 21378101
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
6. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
7. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.
Fung A; Horton S; Zabih V; Denburg A; Gupta S
BMJ Glob Health; 2019; 4(5):e001825. PubMed ID: 31749998
[TBL] [Abstract][Full Text] [Related]
8. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
Woods B; Revill P; Sculpher M; Claxton K
Value Health; 2016 Dec; 19(8):929-935. PubMed ID: 27987642
[TBL] [Abstract][Full Text] [Related]
9. Design, content and financing of an essential national package of health services.
Bobadilla JL; Cowley P; Musgrove P; Saxenian H
Bull World Health Organ; 1994; 72(4):653-62. PubMed ID: 7923544
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
Higashi H; Barendregt JJ
Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of community-based treatment of severe acute malnutrition in children.
Bachmann MO
Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):605-12. PubMed ID: 20950075
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
[TBL] [Abstract][Full Text] [Related]
13. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies.
Ranson MK; Jha P; Chaloupka FJ; Nguyen SN
Nicotine Tob Res; 2002 Aug; 4(3):311-9. PubMed ID: 12215240
[TBL] [Abstract][Full Text] [Related]
14. The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru.
Dave HB; Gordillo L; Yang Z; Zhang MS; Hubbard GB; Olsen TW
Am J Ophthalmol; 2012 Oct; 154(4):750-5. PubMed ID: 22831839
[TBL] [Abstract][Full Text] [Related]
15. Cost-effective outlays for better health outcomes.
Shmueli A
World Health Forum; 1995; 16(3):287-92. PubMed ID: 7546177
[TBL] [Abstract][Full Text] [Related]
16. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.
Pichon-Riviere A; Drummond M; Palacios A; Garcia-Marti S; Augustovski F
Lancet Glob Health; 2023 Jun; 11(6):e833-e842. PubMed ID: 37202020
[TBL] [Abstract][Full Text] [Related]
17. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
18. Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries.
Olgiati P; Bajo E; Bigelli M; De Ronchi D; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):147-54. PubMed ID: 21911028
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.
Goodman CA; Mutemi WM; Baya EK; Willetts A; Marsh V
Health Policy Plan; 2006 Jul; 21(4):275-88. PubMed ID: 16682433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
